ASSESSMENT OF HYPERTRIGLYCERIDEMIA ASSOCIATED RESIDUAL CARDIOVASCULAR RISK IN SECONDARY PREVENTION PATIENTS

被引：0
|
作者：
Gungor, B. [1 ]
Simsek, B. [1 ]
Cinar, T. [2 ]
Inan, D. [3 ]
Genc, D. [3 ]
Yumurtas, A. [1 ]
Vatanoglu, E. [4 ]
Yuksel, G. [5 ]
Karabay, C. [1 ]
机构：
[1] Univ Hlth Sci Dr Siyami Ersek Hosp, Cardiol, Istanbul, Turkiye
[2] Haydarpasa Sultan Abdulhamid Han Training & Res H, Cardiol, Istanbul, Turkiye
[3] Basak Basaksehir Cam & Sakura City Hosp, Cardiol, Istanbul, Turkiye
[4] Karadeniz Eregli State Hosp, Cardiol, Zonguldak, Turkiye
[5] Artvin State Hosp, Cardiol, Artvin, Turkiye
来源：
ATHEROSCLEROSIS | 2023年 / 379卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P443
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [41] CARDIOVASCULAR RISK IN PATIENTS WITH TREATED FAMILIAL HYPERCHOLESTEROLEMIA AND PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA
    WAY, BPJ
    BALL, MJ
    THOROGOOD, M
    COBBE, SM
    MANN, JI
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1986, 79 (07) : 391 - 394
  • [42] RISK STRATIFICATION WITH THE TIMI RISK SCORE FOR SECONDARY PREVENTION AMONG PATIENTS WITH DIABETES AND ELEVATED CARDIOVASCULAR RISK
    Bergmark, Brian
    Bhatt, Deepak
    Bohula, Erin
    Morrow, David
    Steg, Philippe
    Mosenzon, Ofri
    Raz, Itamar
    Braunwald, Eugene
    Scirica, Benjamin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 8 - 8
  • [43] Residual Cardiovascular Risk Despite Secondary Prevention: Data From Contemporary Cardiovascular Outcomes Trials Spanning 2010-2021
    Korjian, Serge
    Daaboul, Yazan
    Bhatt, Deepak L.
    Ridker, Paul M.
    Yeh, Robert W.
    Mehran, Roxana
    Baron, Suzanne J.
    Libby, Peter
    Chi, Gerald
    Kalayci, Arzu
    Nara, Paul
    Shaunik, Alka
    Gibson, C. Michael
    CIRCULATION, 2022, 146
  • [44] Hypertriglyceridemia: Changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease
    Brewer, HB
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (9B): : 3F - 12F
  • [45] Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia
    Kastelein, John J. P.
    HaIlen, Jonas
    Vige, Runar
    Fraser, David A.
    Zhou, Rong
    Hustvedt, Svein Olaf
    Orloff, David G.
    Bays, Harold E.
    CARDIOLOGY, 2016, 135 (01) : 3 - 12
  • [46] Lpa Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins Abstract
    Wei, Wei-qi
    Li, Xiaohui
    Feng, Qiping
    Mosley, Jonathan
    Kullo, Iftikhar
    Shaffer, Christian
    Bland, Sarah
    Peissig, Peggy
    Cox, Nancy
    Stein, Charles M.
    Rotter, Jerome I.
    Edwards, Todd
    Kubo, Michiaki
    Maeda, Shiro
    Horikoshi, Momoko
    Crosslin, David
    Momozawa, Yukihide
    Wilke, Russell
    Larson, Eric A.
    Cronkite, David
    Karlson, Elizabeth
    Jarvik, Gail
    Hripcsak, George
    Shang, Ning
    Pacheco, Jennifer
    Rasmussen-Torvik, Laura
    Lee, Ming Ta Michael
    Ritchie, Marylyn
    Williams, Marc
    Larson, Eric B.
    Roden, Dan M.
    Krauss, Ronald
    Denny, Joshua
    CIRCULATION, 2017, 136
  • [47] Management of Hypertriglyceridemia for Prevention of Atherosclerotic Cardiovascular Disease
    Brinton, Eliot A.
    CARDIOLOGY CLINICS, 2015, 33 (02) : 309 - +
  • [48] Rehabilitation and secondary prevention in patients with cardiovascular diseases
    G. Maisano
    G. Molinis
    D. Tuniz
    M. Valente
    The Italian Journal of Neurological Sciences, 1998, 19 (Suppl 1): : S48 - S50
  • [49] Secondary prevention of cardiovascular events in PAD patients
    Poredos, P.
    Jezovnik, M. K.
    MULTIDISCIPLINARY APPROACH TO CARDIOVASCULAR DISEASES, 2016, : 27 - 30
  • [50] Secondary prevention of cardiovascular disease: Cardiovascular risk assessments and patient education
    Skerratt, Sandra
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 315C - 315C
12345